Advancing Important Drug Candidates
into the Clinic

At Protagonist, we strive to improve patients’ lives through the power of drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate. Today, we have two drug candidates in late-stage development: rusfertide and PN-235 (JNJ-2113).